Avtar S Dhillon insider trades: ONCOSEC MEDICAL (ONCS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Avtar reports to the SEC
and 2 more companies
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 5, 2018 | ONCS | ↓ Sell | 37,575 | $1.39 | $52K | Direct | Jul 6, 2018 (1d) |
| Oct 16, 2015 | ONCS | ↑ Buy | 10,000 | $4.36 | $44K | Direct | Oct 19, 2015 (3d) |
| Feb 14, 2012 | STVF.OB | ↓ Sell | 26,350,000 | $0.00 | $58K | Direct | Mar 21, 2012 (36d) |
| Jul 6, 2011 | INO | ↑ Buy | 20,000 | $0.72 | $14K | Direct | Jul 6, 2011 (0d) |
| Mar 1, 2011 | ONCS.D | ↑ Buy | 9,910,480 | $0.00 | $3K | Direct | Mar 24, 2011 (23d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Avtar S Dhillon's insider trades
Avtar S Dhillon is a director at ONCOSEC MEDICAL (ONCS). Since Mar 1, 2011, Avtar has reported 3 open-market purchases worth $61K and 2 sales worth $110K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (34 filings), option exercises (5 filings), other transactions (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONCS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.